| Date Filed | Type | Description |
| 12/02/2022 |
4
| Deardorf Caren (Chief Commercial Officer) has filed a Form 4 on Magenta Therapeutics, Inc.|
Txns:
| Granted 3,000 shares
@ $0.94, valued at
$2.8k
|
|
| 08/01/2022 |
4
| Deardorf Caren (Chief Commercial Officer) has filed a Form 4 on Magenta Therapeutics, Inc.|
Txns:
| Granted 75,000 options to buy
@ $1.57, valued at
$117.8k
|
|
| 06/21/2022 |
4
| Deardorf Caren (Director) has filed a Form 4 on Crinetics Pharmaceuticals, Inc.|
Txns:
| Granted 4,375 options to buy
@ $18.29, valued at
$80k
|
|
| 06/06/2022 |
4
| Deardorf Caren (Chief Commercial Officer) has filed a Form 4 on Magenta Therapeutics, Inc.|
Txns:
| Granted 3,000 shares
@ $0.99, valued at
$3k
|
|
| 05/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/04/2022 |
4/A
| Deardorf Caren (Director) has filed a Form 4 on Crinetics Pharmaceuticals, Inc.|
Txns:
| Granted 35,000 options to buy
@ $19.3, valued at
$675.5k
|
|
| 03/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/14/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/17/2022 |
4
| Deardorf Caren (Chief Commercial Officer) has filed a Form 4 on Magenta Therapeutics, Inc.|
Txns:
| Granted 75,000 options to buy
@ $3.19, valued at
$239.3k
|
|
| 09/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/08/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |